Randomized Trial Archives - Page 3 of 4 - PsychPartners

Mirtazapine Reduces Meth Use

Addiction Meds Methamphetamine Research Top Research

Mirtazapine Reduces Meth Use

April 2, 2026by Chris Aiken, MD2

Low Dose Naltrexone in Depression

Addiction Meds Depression Inflammation Research

Low Dose Naltrexone in Depression

March 23, 2026by Chris Aiken, MD0

Quetiapine vs Lithium for Treatment-Resistant Depression

Antipsychotics Depression Difficult to Treat Depression Lithium Research Top Research

Quetiapine vs Lithium for Treatment-Resistant Depression

March 23, 2026by Chris Aiken, MD0

Magnetic Therapy (TBS) in Late-Life Depression

Depression Neuromodulation/TMS Research

Magnetic Therapy (TBS) in Late-Life Depression

March 22, 2026by Chris Aiken, MD0

Social Rhythm Therapy Stabilizes Bipolar, With A New Twist

Bipolar Research Research for the Public Therapy

Social Rhythm Therapy Stabilizes Bipolar, With A New Twist

March 22, 2026by Chris Aiken, MD0

For Anhedonia in Depression, Time Light Therapy Right

Depression Light Therapy Research

For Anhedonia in Depression, Time Light Therapy Right

March 21, 2026by Chris Aiken, MD0

Dextromethorphan Helps When Clozapine Fails in Schizophrenia

Antipsychotics Clozapine Research Schizophrenia and Psychosis Top Research

Dextromethorphan Helps When Clozapine Fails in Schizophrenia

March 18, 2026by Chris Aiken, MD5

Light Therapy Improves Blood Sugar in Depression

Light Therapy Research Research for the Public

Light Therapy Improves Blood Sugar in Depression

March 18, 2026by Chris Aiken, MD0

Probiotics Fail in Substance-Induced Depression

Alcohol Cannabis Cocaine Methamphetamine Opioids Research Substance Use Supplements

Probiotics Fail in Substance-Induced Depression

March 18, 2026by Chris Aiken, MD0

Flow: At-home tDCS Approved for Depression

Depression Neuromodulation/TMS Research Research for the Public Top Research

Flow: At-home tDCS Approved for Depression

March 17, 2026by Chris Aiken, MD0

A Wearable Headset for Difficult-to-Treat Depression

Depression Devices Difficult to Treat Depression Neuromodulation/TMS Research Research for the Public Top Research

A Wearable Headset for Difficult-to-Treat Depression

March 15, 2026by Chris Aiken, MD0

Two GLP-1 Agonists Fail in Dementia

Dementia GLP1 Agonists Research Top Research

Two GLP-1 Agonists Fail in Dementia

January 25, 2026by Chris Aiken, MD0

Semaglutide (Ozempic) in Depression

Cognition Depression GLP1 Agonists Research Research for the Public Top Research

Semaglutide (Ozempic) in Depression

December 5, 2025by Chris Aiken, MD0

Lavender for Depression

Depression Research Supplements Top Research

Lavender for Depression

September 27, 2025by Chris Aiken, MD0

A New Version of the STAR*D Trial

Antidepressants Depression Difficult to Treat Depression Lithium Medications Top Research

A New Version of the STAR*D Trial

June 18, 2025by Chris Aiken, MD0

Pramipexole for Treatment-Resistant Depression

Depression Research Top Research

Pramipexole for Treatment-Resistant Depression

June 15, 2025by Chris Aiken, MD0

Guanfacine for Aggression in Prader-Willi Syndrome

Child Psychiatry Medications Research Top Research

Guanfacine for Aggression in Prader-Willi Syndrome

May 21, 2025by Chris Aiken, MD0

GLP1 Agonist Fails in Parkinson’s Disease

GLP1 Agonists Med-Psych Research

GLP1 Agonist Fails in Parkinson’s Disease

February 4, 2025by Chris Aiken, MD0

Adderall for ADHD and Cannabis Use Disorder?

ADHD Cannabis Medications Research Stimulants Substance Use

Adderall for ADHD and Cannabis Use Disorder?

September 4, 2024by Chris Aiken, MD0

Antipsychotic Reduction in Schizophrenia: A Cautionary Tale

Antipsychotics Medications Schizophrenia and Psychosis Top Research

Antipsychotic Reduction in Schizophrenia: A Cautionary Tale

November 10, 2023by Chris Aiken, MD0